Montreal, November 14, 2016 – Desjardins – Innovatech, through the CTS and its program, recently invested $ 250,000 in AlayaCare and its home health care software. This technology provides unprecedented visibility for stakeholders, personal support services and other employees.

“AlayaCare is proud to be part of the CTS ecosystem”, said Adrian Schauer, CEO and co-founder of AlayaCare. “With our software, we are constantly researching and integrating medical equipment. We are convinced that our colleagues, who have integrated the CTS portfolio, will be a source of innovation for our clients. We also believe that our platform will be used to innovate like a medical device. ”

“AlayaCare has been able to analyze and understand the home care market by proposing a suitable and modern tool,” said Guillaume Hervé, chairman of CTS. Desjardins – Innovatech, through the CTS program, is supporting this company to develop its international network. ”

The co-founders Adrian Schauer and Brady Murphy are willing to develop this technology that does not meet current expectations. Intuition and ease of handling are the hallmarks of AlayaCare in order to be suitable for the largest number of patients and professionals. This open programming interface offers a clear and secure integration that is inherent to the needs of the medical community.

The heart of the software is the connection between a professional of the sector and a remote patient. AlayaCare pushes the limits of virtual to optimize the movements in order to treat as many patients as possible. Thus, they can also benefit from monitoring and planning on all their devices and always have access to the family portal.


It is a new generation of services and medical approach that the company develops with AlayaCare:

– Improve income through automated learning

– Advance optimization to maximize resources

– Use of built-in portable devices to provide vital patient data.


With the support of the CTS, Desjardins – Innovatech wishes to accompany AlayaCare in the development of a technology in demand in the field of health. The investment will enable the company to develop the software and take a new step to develop their international network.


About Alayacare

AlayaCare is a provider of revolutionary cloud-based home healthcare software. With an end-to-end solution spanning clinical documentation, back office functionality, client and family portals, remote patient monitoring, and mobile care worker functionality, they offer a platform for agencies to propel towards innovation and home care of the future.


About CTS

CTS is an accelerator of companies in the field of medical technologies which offers them to develop faster and increases their chances of success. The goal of the CTS is to offer start-up companies a unique proposition with structured framework that allows them to focus on developing their technology, reaching market dynamics and gaining the visibility they need to start and develop internationally.


About Desjardins – Innovatech

Created in 2005, the Desjardins – Innovatech fund was created by the initiative of the Government of Québec and Capital régional et coopératif Desjardins. With more than $ 55 million invested in nearly 40 companies and funds, Desjardins – Innovatech’s main mission is to promote and support companies from Quebec, who involved in the development of technological innovation or Industrialists and the new generation of Quebec innovation entrepreneurs, with their capital financing. In order to fulfill its mission, the fund joins forces with other players in the technological field – specialized investment funds, entrepreneurs, financial angels, technological company’s accelerators – contributing to increase PME in terms of job creation and economic development.

For additional information (journalists only)


Adrian Schauer

CEO and co-founder

+1 855-858-5214


Romain Lortille Bruel

Director of Business Development

514-274-1001 or 514-808-9775

Desjardins – Innovatech

Richard Lacasse

Media spokesperson

418-835-8444 or 1-866-835-8444, ext. 556 3163